• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Contact


Email

elena.schneiderfutschik@unimelb.edu.au

Credentials


Position
Principal Research Fellow
Department of Biochemistry and Pharmacology
Education
Doctorate
Monash University
ORCID

0000-0001-6044-4824

A/Prof Elena Schneider-Futschik

Principal Research Fellow
Department of Biochemistry and Pharmacology

107 Scholarly works
13 Projects

HIGHLIGHTS

  • 2026

    Journal article

    When Neutrophils Go Rogue: Dysregulated Inflammation in Airway Diseases and Implications for Therapy
    DOI: 10.1021/acsptsci.5c00640
  • 2026

    Journal article

    Exploring a genetic basis for the metabolic perturbations in ME/CFS using UK biobank
    DOI: 10.1016/j.isci.2025.114316
  • 2026

    Journal article

    A chronobiology-based protocol for multi-omic mapping of menstrual cycle and diurnal rhythms in ME/CFS and long COVID
    DOI: 10.1038/s44294-025-00120-9
  • 2025

    Journal article

    PRenatal mOdulator treatment to PrEvent CF complicaTions (PROTECT) workshop report
    DOI: 10.1016/j.jcf.2025.07.015
  • 2025

    Research grants (ARC, NHMRC, MRFF)

    Exposure to Cystic Fibrosis Modulators During Pregnancy to Mitigate Pathology Development in Offspring
  • 2024

    Research grants (other domestic)

    Investigating Trikafta Drug Exposure During Pregnancy
  • 2019

    Research Grant

    Systems Pharmacology of Cystic Fibrosis Transmembrane Regulator Correctors and Potentiators
Elena Schneider-Futschik

Latest Honours,
Awards and Fellowships


2019
TSANZ
2018
MDHS ECR
2018
Certara New Investigator Award (ASCEPT)
2018
NHMRC Fellowship (NHMRCF)

RECENT SCHOLARLY WORKS

  • 2025

    Journal article

    A Perspective on the Role of Metformin in Treating Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Long COVID
    DOI: 10.1021/acsptsci.5c00229
  • 2025

    Conference Proceedings

    Fetal Exposure and Lens-Related Ocular Changes Following In-Utero Administration of Elexacaftor/Tezacaftor/Ivacaftor in a Rat Model
    DOI: 10.1183/13993003.congress-2025.oa3330
  • 2025

    Journal article

    Hyperfiltration and Elevated Fractional Excretion of Magnesium in Children with Cystic Fibrosis
    DOI: 10.1021/acsptsci.5c00330
  • 2025

    Journal article

    WS06.05Fetal drug exposure after maternally administered elexacaftor/tezacaftor/ivacaftor in a rat model
    DOI: 10.1016/j.jcf.2025.03.526
  • 2025

    Journal article

    EPS8.05Investigating the variability in CFTR modulator responses through pharmacomicrobiomics
    DOI: 10.1016/j.jcf.2025.03.662
  • 2025

    Journal article

    Investigating the Potential Hearing Impairment and Ototoxicity in Children up to Six Years With Cystic Fibrosis After Aminoglycoside Exposure (PIANO-CF Extension)
    DOI: 10.1002/ppul.27505

RECENT PROJECTS

  • 2026

    Research grants (other domestic)

    Towards Early Diagnosis: Uncovering Biomarkers of Colorectal Cancer in Adults With Cystic Fibrosis
  • 2025

    Research grants (ARC, NHMRC, MRFF)

    Energy Inefficiency in Long COVID and ME/CFS

We acknowledge and pay respect to the Traditional Owners of the lands upon which our campuses are situated

Read about our commitment to reconciliation  

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia


View all Campus locations  
facebookIconlinkedinIconinstagramIcontwitterIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy  |  VaxFACTS

CRICOS number: 00116K     ABN: 84 002 705 224